Keizo Sugimachi Selected Research

Keizo Sugimachi Research Topics

Disease

40	Neoplasms (Cancer) 07/2023 - 08/2000
14	Carcinoma (Carcinomatosis) 09/2003 - 01/2002
13	Hepatocellular Carcinoma (Hepatoma) 04/2007 - 01/2002
9	Stomach Neoplasms (Stomach Cancer) 05/2004 - 01/2002
8	Lymphatic Metastasis 05/2004 - 08/2000
7	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2003 - 03/2002
6	Breast Neoplasms (Breast Cancer) 04/2005 - 01/2002
6	Hemorrhage 05/2004 - 01/2002
6	Carcinogenesis 03/2003 - 01/2002
5	Neoplasm Metastasis (Metastasis) 09/2003 - 01/2002
5	Liver Diseases (Liver Disease) 08/2002 - 01/2002
4	Esophageal and Gastric Varices (Esophageal Varices) 05/2004 - 01/2002
4	Fibrosis (Cirrhosis) 05/2004 - 01/2002
4	Cholangiocarcinoma 01/2004 - 01/2002
3	Adenocarcinoma 01/2017 - 05/2002
3	Ischemia 09/2003 - 01/2002
3	Esophageal Squamous Cell Carcinoma 03/2003 - 01/2002
3	Esophageal Neoplasms (Esophageal Cancer) 12/2002 - 11/2002
3	Hyperthermia 11/2002 - 01/2002
3	Septic Shock (Toxic Shock Syndrome) 09/2002 - 01/2002
3	Acute Liver Failure (Fulminant Hepatic Failure) 03/2002 - 01/2002
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2002 - 01/2002
2	Lung Neoplasms (Lung Cancer) 07/2023 - 01/2017
2	Pathologic Constriction (Stenosis) 03/2016 - 05/2002
2	Reperfusion Injury 05/2006 - 09/2003
2	End Stage Liver Disease 07/2005 - 01/2002
2	Colorectal Neoplasms (Colorectal Cancer) 01/2005 - 10/2003
2	Liver Failure 05/2004 - 01/2003
2	Adenocarcinoma of Lung 01/2004 - 01/2002
2	Infections 05/2003 - 01/2002
2	Hyperplasia 06/2002 - 06/2002
2	Portal Hypertension 05/2002 - 01/2002
2	Rectal Neoplasms (Rectal Cancer) 01/2002 - 01/2002
1	Hypothyroidism 07/2023
1	Fatigue 07/2023
1	Stevens-Johnson Syndrome (Lyell's Syndrome) 01/2017

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 07/2003 - 01/2002
6	Messenger RNA (mRNA)IBA 07/2003 - 02/2002
4	Matrix Metalloproteinases (MMPs)IBA 01/2004 - 01/2002
4	Cadherins (E-Cadherin)IBA 07/2003 - 01/2002
3	polyurethane foamIBA 04/2007 - 01/2002
3	UracilIBA 04/2005 - 01/2003
3	TegafurIBA 04/2005 - 01/2003
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2005 - 01/2002
3	Indicators and Reagents (Reagents)IBA 03/2003 - 03/2002
3	DNA (Deoxyribonucleic Acid)IBA 11/2002 - 01/2002
3	Thrombospondin 1IBA 05/2002 - 01/2002
3	Monoclonal AntibodiesIBA 04/2002 - 01/2002
2	Anti-Bacterial Agents (Antibiotics)IBA 03/2016 - 03/2002
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2006 - 01/2002
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2005 - 03/2003
2	Tamoxifen FDA LinkGeneric 04/2005 - 01/2003
2	Fluorouracil (Carac)FDA LinkGeneric 04/2005 - 11/2002
2	Cisplatin (Platino)FDA LinkGeneric 09/2003 - 01/2002
2	AntioxidantsIBA 09/2003 - 11/2002
2	C-Reactive ProteinIBA 03/2003 - 01/2002
2	doxifluridineIBA 03/2003 - 03/2002
2	AngiopoietinsIBA 03/2003 - 04/2002
2	Conjugated Linoleic AcidsIBA 12/2002 - 12/2002
2	RNA (Ribonucleic Acid)IBA 12/2002 - 01/2002
2	Dihydrotachysterol (AT 10)IBA 12/2002 - 01/2002
2	Phospholipids (Phosphatides)FDA LinkGeneric 12/2002 - 05/2002
2	beta CateninIBA 12/2002 - 03/2002
2	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2002 - 11/2002
2	EndotoxinsIBA 09/2002 - 03/2002
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2002 - 05/2002
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 04/2002 - 01/2002
2	LigandsIBA 04/2002 - 01/2002
2	Transforming Growth Factor beta (TGF-beta)IBA 02/2002 - 01/2002
2	Transforming Growth Factor beta1 (TGF beta 1)IBA 02/2002 - 01/2002
2	Hematoxylin (Haematoxylon)IBA 01/2002 - 01/2002
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2002 - 01/2002
1	Adrenocorticotropic Hormone (ACTH)FDA Link 07/2023
1	pembrolizumabIBA 07/2023
1	Thyroxine (Levothyroxine)FDA LinkGeneric 07/2023
1	Immune Checkpoint InhibitorsIBA 07/2023
1	Isolated ACTH DeficiencyIBA 07/2023
1	Ointments (Pastes)IBA 01/2017
1	NivolumabIBA 01/2017
1	SteroidsIBA 01/2017
1	Anaplastic Lymphoma KinaseIBA 01/2017

Therapy/Procedure

14	Therapeutics 07/2023 - 08/2000
8	Drug Therapy (Chemotherapy) 07/2023 - 01/2002
8	Liver Transplantation 05/2006 - 01/2002
5	Splenectomy 09/2003 - 01/2002
4	Lymph Node Excision (Lymph Node Dissection) 05/2004 - 08/2000
4	Sclerotherapy 05/2004 - 01/2002
4	Adjuvant Chemotherapy 10/2003 - 01/2003
3	Esophagectomy 09/2003 - 01/2002
3	Radiotherapy 05/2003 - 01/2002
2	Stents 03/2016 - 02/2003
2	Artificial Liver (Bioartificial Liver) 04/2007 - 01/2003
2	Gastrectomy 05/2004 - 04/2002
2	Segmental Mastectomy (Lumpectomy) 05/2004 - 06/2002
2	Palliative Care (Palliative Therapy) 05/2003 - 01/2002
2	Hepatectomy 05/2003 - 01/2002
2	Laparotomy 04/2003 - 03/2003
2	Transplantation 12/2002 - 03/2002
2	Prostheses and Implants (Prosthesis) 11/2002 - 01/2002
1	Immunotherapy 01/2017